Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: Implications for the immunopathogenesis of muscle autoimmune diseases

Journal of Neuroimmunology

Volumn 68, Issue 1-2, 1996, Pages 53-60

  Mantegazza, Renato ^a   Gebbia, Marinella ^a   Mora, Marina ^a   Barresi, Rita ^a   Bernasconi, Pia ^a   Baggi, Fulvio ^a   Cornelio, Ferdinando ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Autoimmunity; Interferon ; Major histocompatibility complex; Muscle cell

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOSIN; RECOMBINANT GAMMA INTERFERON;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CELL MATURATION; CONTROLLED STUDY; ETIOLOGY; HUMAN; HUMAN CELL; MUSCLE CELL; MUSCLE DISEASE; MYOBLAST; PRIORITY JOURNAL;

EID: 0030219707     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00068-9     Document Type: Article

References (53)

1. Babbitt B.P., Allen P.M., Matsueda G., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317:1985;359-361.
2. Baggi F., Nicolle M., Vincent A., Matsuo H., Willcox N., Newsom-Davis J. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient. J. Neuroimmunol. 46:1993;57-66.
3. Bao S., King N.J.C., Dosremedios C.G. Elevated MHC-class-I and class-II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon. Immunol. Cell Biol. 68:1990;235-241.
4. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P. MHC class I, MHC class II and the intercellular adhesion molecule-1 [ICAM-1] expression in inflammatory myopathies. Clin. Exp. Immunol. 95:1994;166-172.
5. Basham T.Y., Nickoloff B.J., Merigan T.C., Morhenn V.B. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J. Invest. Dermatol. 83:1984;88-90.
6. Beauchamp J.R., Abraham D.J., Bou-Gharios G., Partridge T.A., Olsen I. Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. Am. J. Pathol. 140:1992;387-401.
7. Blau H.M., Webster C. Isolation and characterization of human muscle cells. Proc. Natl. Acad. Sci. USA. 78:1981;5623-5627.
8. Bottazzo G.F., Pujol-Borrel R., Hanafusa T. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet. 2:1983;1115-1118.
9. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G.F., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulinitis. N. Engl. J. Med. 313:1985;353-360.
10. Byrne B.C., Li J.J., Sninsky J., Poiesz B.J. Detection of HIV-1 RNA sequences by in vitro DNA amplification. Nucleic Acids Res. 16:1988;4165.
11. Chesnut R.W., Colon S.M., Grey H.M. Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison. J. Immunol. 128:1982;1764-1768.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
13. Daar A.S., Fuggle S.V., Fabre J.W., Ting A., Morris P.J. The detailed distribution of HLA-A,B,C antigens in normal human organs. Transplantation. 38:1984;287-292.
14. Daar A.S., Fuggle S.V., Fabre J.W., Ting A., Morris P.J. The detailed distribution of MHC class II antigens in normal human organs. Transplantation. 38:1984;293-298.
15. Dalakas M.C. Polymyositis, dermatomyositis, and inclusion body myositis. N. Engl. J. Med. 325:1991;1487-1498.
16. De Lerma Barbaro A., Sartoris S., Tosi G., Nicolis M., Accolla R.S. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP molecules. J. Immunol. 153:1994;4530-4538.
17. Didier D.K., Schiffenbauer J., Woulfe S.L., Zacheis M., Schwartz B.D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc. Natl. Acad. Sci. USA. 85:1988;7322-7326.
18. Emslie-Smith A.M., Engel A.G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann. Neurol. 27:1990;343-350.
19. Emslie-Smith A.M., Arahata K., Engel A.G. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20:1989;224-231.
20. Engel A.G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16:1984;209-215.
21. Farrell, F.X., Sax, C.M., Garzon, R.J. and Zehner, Z.E. (1989) Regulation of vimentin expression during myogenesis. In: ed. L.H. Kedes and F.E. Stockdale, Cellular and Molecular Biology of Muscle Development. Alan R. Liss Inc., New York, pp. 777-788.
22. Fontana A., Erb P., Pircher H., Zinkernagel R., Weber E., Fierz W. Astrocytes as antigen presenting cells: Part II. Unlike H-2K-dependent cytotoxic cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-γ J. Neuroimmunol. 12:1986;15-28.
23. Frelinger J.A., Niederhuber J.E., Shreffler D.C. Inhibition of immune responses in vitro by specific antiserum to Ia antigens. Science. 188:1975;268-270.
24. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:1992;13-49.
25. Goebels N., Michaelis D., Wekerle H., Hohlfeld R. Human myoblasts as antigen-presenting cells. J. Immunol. 149:1992;661-667.
26. Halper J., Fu S.M., Wang C.Y., Winchester R., Kunkel H.G. Patterns of expression of "Ia like" antigens during the terminal stages of B cell development. J. Immunol. 120:1978;1480-1484.
27. Higuchi I., Nerenberg M., Ijichi T., Fukunaga H., Arimura K., Usuki F., Kuriyama M., Osame M. Vacuolar myositis with expression of both MHC class I and class II antigens on skeletal muscle fibers. J. Neurol. Sci. 106:1991;60-66.
28. Hohlfeld R., Engel A.G. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am. J. Pathol. 136:1990;503-508.
29. Hohlfeld R., Engel A.G. The immunobiology of muscle. Immunol. Today. 15:1994;269-274.
30. Honda H., Rostani A. Expression of major histocompatibility complex class I antigens in rat muscle cultures: the possible development role in myogenesis. Proc. Natl. Acad. Sci. USA. 86:1989;7007-7011.
31. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann. Neurol. 23:1988;64-72.
32. Kobayashi T., Askanas V., Engel W.K. Human muscle cultured in monolayer and cocultured with fetal rat spinal cord: importance of dorsal root ganglia for achieving sucessful functional innervation. J. Neurosci. 7:1987;3131-3141.
33. Krieger J.I., Grammer S.F., Grey H.M., Chesnut R.W. Antigen presentation by splenic B cells: resting B cell are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J. Immunol. 135:1985;2937-2941.
34. Lanier L.L., Testi R., Binal J., Phillips J.H. Identity of Leu-19 [CD56] leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169:1989;2233-2238.
35. Liou H.C., Boothby M.R., Finn P.W., Davidon R., Nabavi N., Zeleznikle N.J., Ting J.P.Y., Glimcher L.H. A new member of the leucine zipper class of proteins that binds to the HLA DR α promoter. Science. 247:1990;1581-1584.
36. Londei M., Lamb J.R., Bottazzo G.F., Feldmann M. Epithelial cells expressing aberrant MHC-class II determinants can present antigen to cloned human T cells. Nature. 312:1984;639-641.
37. Maffei A., Scarpellino L., Bernard M., Carra G., Jotterand-Bellomo M., Guardiola J., Accolla R.S. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages. J. Immunol. 139:1987;942-948.
38. Mantegazza R., Hughes S.M., Mitchell D., Travis M., Blau H.M., Steinman L. Modulation of MHC-class II antigen expression in human myoblasts after treatment with IFN-g. Neurology. 41:1991;1128-1132.
39. Mantegazza R., Andreetta F., Bernasconi P., Baggi F., Oksenberg J.R., Simoncini O., Mora M., Cornelio F., Steinman L. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J. Clin. Invest. 91:1993;2880-2886.
40. McDuall R.M., Dunn M.J., Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J. Neurol. Sci. 89:1989;213-226.
41. Michaelis D., Goebels N., Hohlfeld R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am. J. Pathol. 143:1993;1142-1149.
42. Miranda A.F., Bonilla E., Martucci G., Moraes C.T., Hays A.P., Di Mauro S. Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. Am. J. Pathol. 132:1988;410-416.
43. Morandi L., Mora M., Bernasconi P., Mantegazza R., Gebbia M., Balestrini M.R., Cornelio F. Very small dystrophin molecule in a family with a mild form of Becker dystrophy. Neuromuscular Disord. 3:1993;65-70.
44. Panayi G.S., Lanchbury J.S., Kingsley G.H. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoids arthritis. Arthritis Rheum. 35:1992;729-735.
45. Park-Matsumoto Y.C., Kameda N., Kobayashi T., Tsukagoshi H. Developmental study of the expression of dystrophin in cultured human muscle aneurally and innervated with fetal rat spinal cord. Brain Res. 565:1991;280-289.
46. Pober J.S., Collins T., Gimbrone M.A.J., Cotran R.S., Gitlin J.D., Fiers W., Clayberger C., Krensky A.M., Burakoff S.J., Reiss C.S. Lymphocytes recognizes human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant interferon. Nature. 305:1983;726-729.
47. Reith W., Herrero-Sanchez C., Kobr M., Silacci P., Berte C., Barras E., Fey S., Mach B. MHC class II regulatory factor RFX has a novel DNA- binding domain and a functionally indipendent dimerization domain. Genes Dev. 4:1990;1528-1540.
48. Roy R., Dansereau G., Tremblay J.P., Belles-Isles M., Huard J., Labrecque C., Bouchard J.P. Expression of major histocompatibility complex antigens on human myoblasts. Transplant. Proc. 23:1991;799-801.
49. Schoepfer R., Luther M., Lindstrom J. The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. FEBS Lett. 226:1988;235-240.
50. Teyton L., Lotteau V., Turmel P., Arenzana-Seisdedos F., Virelizier J.-L., Pujol J.-P., Loyau G., Piatier-Tonneau D., Auffray C., Charron D.J. HLA DR, DQ and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study. J. Immunol. 138:1987;1730-1738.
51. Traugott U. Multiple sclerosis: relevance of Class I and Class II MHC- expressing cells to lesion development. J. Neuroimmunol. 16:1987;283-302.
52. Trinchieri G., Perussia B. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today. 6:1985;131-136.
53. Webster C., Pavlath G.K., Parks D.R., Walsh F.S., Blau H.M. Isolation of human myoblasts with the fluorescence-activated cell sorter. Exp. Cell Res. 174:1988;252-265.